NewsBenzingaCapricor Therapeutics Presents New Data From Ongoing HOPE-3 OLE Study For Its Lead Asset, Deramiocel, For Treatment Of Upper Limb Impairment In DMD, At 31st Annual Congress Of WMS In Hiroshima Capricor Therapeutics Presents New Data From Ongoing HOPE-3 OLE Study For Its Lead Asset, Deramiocel, For Treatment Of Upper Limb Impairment In DMD, At 31st Annual Congress Of WMS In Hiroshima Benzinga 2026.10.05 13:07 (GMT+0) Open on Benzinga Other news If You Invested $1000 In Eaton Corp Stock 10 Years Ago, You Would Have This Much Today Here’s How Much You Would Have Made Owning Suncor Energy Stock In The Last 5 Years Goldman vs. JPMorgan: Both Raised Their Dividends. Which Bank Is the Better Buy? $1000 Invested In Barrick Mining 5 Years Ago Would Be Worth This Much Today New Cracks in AI Trade Push Wall Street to Worst Week Since June I'm Not Able To Upgrade Washington Trust Bancorp Just Yet (NASDAQ:WASH)
